SEARCH
Quotes News NAV
Balance Sheet Markets  >  Corporate Information  >   Balance Sheet
Accretion Nutraveda Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544694 INE1KVQ01019 42.405663 Not Listed 0 133.98 0 0 10
      ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
SOURCES OF FUNDS :   
Share Capital 0.490.360.36
Reserves Total 4.860.72-0.10
Equity Share Warrants0.000.000.00
Equity Application Money0.000.000.00
Total Shareholders Funds5.351.080.26
Secured Loans 1.931.421.30
Unsecured Loans 1.930.750.67
Total Debt3.862.171.97
Other Liabilities0.000.000.00
Total Liabilities9.213.252.23
APPLICATION OF FUNDS :   
Gross Block 3.002.031.97
Less : Accumulated Depreciation 0.990.750.48
Less:Impairment of Assets0.000.000.00
Net Block 2.011.281.49
Lease Adjustment0.000.000.00
Capital Work in Progress0.000.100.00
Producing Properties0.000.000.00
Investments 0.000.000.00
Current Assets, Loans & Advances   
Inventories 4.592.381.30
Sundry Debtors 3.270.250.80
Cash and Bank Balance0.020.120.09
Loans and Advances 0.970.510.39
Total Current Assets8.853.252.57
Less : Current Liabilities and Provisions   
Current Liabilities 1.061.271.80
Provisions 0.560.100.00
Total Current Liabilities & Provisions1.621.371.80
Net Current Assets7.221.880.77
Miscellaneous Expenses not written off 0.000.000.00
Deferred Tax Assets0.000.000.00
Deferred Tax Liability0.030.010.02
Net Deferred Tax-0.03-0.01-0.02
Other Assets0.000.000.00
Total Assets9.213.262.24
Contingent Liabilities0.000.000.00